Pharmarise Holdings Corp. · TSE:2796
Pharmarise — FY2011 Earnings Presentation
35 slides from Pharmarise's earnings presentation, 2011
Slide 1: Company Information Session
(7 Pharmarise HOLDINGS Ph harmarise 4) Hole ae gs Company Information Sessioi D7P-VPA KRW 4Y IAA eS tthWAS ae can 3723475318 JASDAQ SE$1—K : 2796
Slide 2: Contents
Pharmarise Holdings Company Information Session SHR (7 Pharmarise HOLDINGS Contents o mii 07 Selene 2 Aue EHS 0 ARBRE
Slide 3: Pharmarise Holdings Overview
(2 Pharmarise HOLDINGS Pharmarise Holdings V1 SHRAAA
Slide 4: Pharmarise Holdings Corporation company profile
( Pharmarise a HOLDINGS Sime tt 8% DP-VIA AK FavI ARASH Pharmarise Holdings Corporation A tt 7164-0011 RRABhHKPR1T B38815 RE RMR AEP FRA am 198476A BA 815,545 (201146531 BRE) (RAR GER SD) 799% (5 SSeR6N4 272) GHG : 201147531 BRE) EKOBRAS HRA AKO PARAS ORES (Sta) (S820 (2011527 ARE) = SID - PEt 19415
Slide 5: Business description
SAO Sime CREED RRBSSRCMHOMACRS (14) RR Sexi EYED RRB RE SEC Schaal aOR iia CELE (A) view skla Gi () ba) SEF SME Zh ETH) ICARDA EAAM GRIP N54 ARS IRA APT) ZERIT (4) ARVEEBAAl BY 9 — Ge (Me) ROE YS —) e Fatt ORE ERO (4) LY CLA RSeMNS Ht | yt > (tk) RRMEDS IP —VS41 A (MH) (CHS BES | LED REBHIO (#8) MRE
Slide 6: Group structure (July 2011)
PD \L—FiRH (201147 A 8) SiRe TIV-—FEAKC 1 94 58H (HEN — ZA 164 55H) WRF At TW TROBE 2709212 NLR PRAS1G100% BABIOHAY GRRE) EB IIS tt fa [ aa CR) a 1k a SES 1958 Ree Ne a) APSRIS100% BASSES dom) | 777 o> (A) BRERA LY 9 — KE) See 4k PARE68.2% BASIE Grae) | ARE IP-VS4t An WF YTA CH) | REE Ed WHER. SHER
Slide 7: M&A history and growth
(2 Pharmarise HOLDINGS Suge (sa) FN TE LO HE M&A ARE PUIRHS M&A 30 204 DUBTSEF (BFS) 200 194 come (BE) 2010 Mee) Z< BES ER) TEAMFIESE (BB) AUS AIR AOS) 2011 iene te este) 2011 Wis B15 BD) 2011 [es BFR (Rm) Fafa Aei 201 0% PPS Si (BLL) 2004% 2005¢¢ 2006 20078 2008s 20098 20108 201 1s 2012 SAR SARB SA
Slide 8: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings V1 SHRAEA
Slide 9: Pharmarise
Pharmarise HOLDINGS an) sans REA PSEIS. RICA -REERSPROSNET , ARSE SIPS Hit RICSITS £2 RTM Pharmarise Holdings Corporation Company Information Session
Slide 10: (2 Pharmarise
(2 Pharmarise HOLDINGS Pharmarise Holdings Corporation Company Information Session
Slide 11: ( Pharmarise
( Pharmarise Va HOLDINGS an © HBSRaael |) bn Bbc OH C JRE ORV CY 12 OBSILGDET SX DAP DENS AI 1s [eae [ees eee on ession Company Information
Slide 12: ( Pharmarise
( Pharmarise id HOLDINGS 2S @ ite ROLE Se ateae “EO+A—DVIA— > HbR REBAL CUSIE SHC. MARAE 4 O— A oj RE hm, ) DSL Ya REIICB NAMED AER BR cha (45) 600 650 500 556 400 ——__________| 47] 300 338 200845F 200945 201045F 2011465R 201 24¢5F (+H) Pharmarise Holdings Corporation Company Information Session
Slide 13: Business results (1)
#8 6) Vo RY IAORWAA (1) BAH | (RECUR MRE CA SHRI LRU YIERELCSA C PANICRUMD Ste lal hosRERROWHMS WSN—A) Lh - Biwinn KRUPA ‘ : e BERECEI< REIN, a HRUIAUYIERE _@- . ° 20.2 WBICITL HEI TAVYIO Sii2 ESE 199 e ery 4 BEORARIC WUT ELIVYT 5 KHA AARTT Ry IRR BS 20075F 2008465A 2009%5A 2010%5F 2011465A Pharmari
Slide 14: Business results (2)
( Pharmarise id HOLDINGS EB 6) Vo RY IAORW AA (2) Se ateae RHR oo (VLRUY7) OP AA este lett REEORAO SB RERROVO MN PT VICBGODS 20 BLU RES OO heh SLED oI8h PARP ADEN sie PRICRHD dS oie JRRELEARAD AAD Die ZSECFAMS dE EO th (BEL /%) 37.6 HHKAAARAMMS EER ROKK RAH (200841 1 A20AER) LH) Pharmarise Holdings
Slide 15: Business results (3)
( Pharmarise ia HOLDINGS © VIRUYAINORW HAA (3) BERDOVIAUYIRBE BHOITRV yIRRRRE ME Onm-LXN—YA\ORRBROSROBR OnE A sHINROBSS. DE - Bethe 7 SL< SHAT AROAR CFMFHESHRRORAR QEMFHEASHtRRT —T OBRCE OBR OQRHAROBRAR QBURRT— FI OARCE OBR @RET—I OBRAR @QRARKE COREET —5 OAREE OBR OQREHAROAAR OMRUBOT—I OBREE Ota (AI
Slide 16: Initiatives (1)
(BZ Pharmarise FTC TSEE ea SEBE (1) — MEN INEe HATS ea AE @ W242 OR =e m| COTS 40 le ee Pharmarise Holdings Corporation Company Information Session
Slide 17: Initiatives (2)
(BZ Pharmarise FTC TSEE DEBE (2) [53 —FABR Son] PRES AAS. MBN ES zi l CWS MICRMICB IC AMM Cee NceRAS URYEPAF FAL POVEMVUMITHWSET aA COBRA HT 20112F5AHOse Liald 1 (21 0075F (Hb 150%) Pharmarise Holdings Corporation Company Information Session
Slide 18: Initiatives (1)
(BZ Pharmarise SAL O FC HHO HI (1) a SAIEMEL C OAM sae? AF IVIS. DHS PHASHASS C mee SALHBL Cees Pharmarise Holdings Corporation Company Information Session
Slide 19: Initiatives (2)
( Pharmarise ia HOLDINGS SEALED RCHRO Ele (2) ane sTeP 8 PRI XY NINE Est Rae STEP 5 A342 BGHE STEP 4 RBEBALIT Y THE STEP 3 OJTHE MESH STEP 2 SAHA sep | — (FI Eif) ata 15 28 388 Pharmarise Holdings Corporation Company Information Session
Slide 20: Initiatives (3)
CG ¥ Pharmarise HOLDINGS _ SACO RRC ROEM (3) eee Pharmarise Holdings Corporation Company Information Session
Slide 21: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings DVT SHRAEA
Slide 22: ( Pharmarise
( Pharmarise ia HOLDINGS SttT)L—-TFOMERT X-Y SHOBSIML. MANET STL, BNUCRMEMEELT S ALR Rn WReHA CES MWR ROR GOS 4 ULC Ay kel SORMOMW = - v | \ FRA Pharmarise Holdings Corporation Company Information Session
Slide 23: ( Pharmarise
( Pharmarise ia HOLDINGS 6D ORAS SHOBSIML BH AURA @AFTSCCC. BNCRVERTARTS 4HoOxBSle Wd S BERS TOE) 2 aa BSI ORB fen TUTE) S| Sy eyez Fed OBES Pharmarise Holdings Corporation Company Information Session
Slide 24: (7 Pharmarise
(7 Pharmarise ALSO KS PWFT SY KBE DP-VIARZISYREMLAITS HoMICHIFSRAEZEMLENS “ W/IN\DRBIE AIO Neto RRR BRT S KATZ Pharmarise Holdings Corporation Company Information Session
Slide 25: (7 Pharmarise
(7 Pharmarise ARE AT SAUWISYASR (201147 Abe) AUBEES => _ vA Katy Miz Ak FESO fips! Aa HbeRITIFED RE EBE CE RR2 1 EE HSH) [EE 50% DE | 40% ES 0% RIB I) 40% ony 65.4% (ERR20% 1 2 RABI) Pharmarise Holdings Corporation Company Information Session
Slide 26: ( Pharmarise
( Pharmarise HOLDINGS ALR RH DT IL—FHERO IS VEE SABA ET IL—-F RES KC F JU— DT Ett Va IWF MRHIIGHETS [4 SeRieAaB RENT PYSBES ES feral = [| He ANEB ny BAB BRAG Pharmarise Holdings Corporation Company Information Session 25
Slide 27: (ZB Pharmarise
(ZB Pharmarise DP-VI>ITARBE—)L (BE) 4 Mh DP-VI1ARRE IL 2 EB BS tt Dr-VotAh) Pr € th SLOT REALS RT BS JIRID—-ADAAP IVE DIESB7~MWSBD R = FLMRERARIF (th) SRIGEOF At) EB tw BS FU=y710, 32. 181. SOS st18 R235 ce LB: 48085 (107A“—2) Bsr: 5280 Pharmarise Holdings Corporation Company Information Session
Slide 28: cpARBYIC
cpARBYIC Mika Seri. Biro Y—ERABALE BMeBiEs
Slide 29: BS slSiSS (COC (MB)
BS slSiSS (COC (MB) ALR RH ARATE *FM2343A 288 RRFATEL 4,7 008K (HERERIEIC ML T 23.15%) arb PRR 470BAF AZAROBE PMA al KORA aS alse WWIECP< 1.100KK — (iL IaE AHO EESRERAT EH) WNT IILAYh 1,100 RIL ALR) pig) 1.100K = GRSILKO RSE) ee 1,000K eM “WPM «200K CERO) 20th 200K Pharmarise Holdings Corporation Co
Slide 30: B— SB SIMS (CDT (BAN)
B— SB SIMS (CDT (BAN) ACRES Sate \ ANTINILPHRCESABHBIN-BF-E 5 SBIR VD) weeremEs 3 SE Ov ECPI IID AY, PALER) CSS ES VIRUYIER THROAT EBS [Hot | (CBU CRIA EES Ea db PRRSS (HH) CIEE aie VIRUY TPMT SHAM EROS S w FiO BEReICkS ATlFAiO b= Vesirver ie ) BBC hORSRZeTS a) BCAAMEIL. MBBBORED EES SHA (24/589) CO
Slide 31: Pharmarise Holdings
(2 Pharmarise HOLDINGS Pharmarise Holdings DVT SHRAEA
Slide 32: Results summary (FY ended May 2011)
( Pharmarise ia HOLDINGS Wt RB/\TITh (2011425888) AER -— © BURARHELEMBARER (=A, IED 7 —\. ACH) — © *LRERE—ILICKSINAEDI — © Br Sst Lo inact — © tA DROME (AT —ILXUY hORER) 6 ea — © Rat ORA HER. VIRUY 7 OPE) 7 — © BEWXOUS SRA CERT) At BAA % 2010%5A 2011465A TLs 23,416 26,825 Be tlig 982 1,496 Flat 773
Slide 33: Forecast (FY ending May 2012)
(2 Pharmarise HOLDINGS RARE Ete si 48 (2012425A) RIVA J POINT: . @ 18/281 ,549875E : BRFESEL+2% CSTR 1 OSS (HEAR 204 (588) © SF ZS 0088 1 326A : A -WROMEC+HRMOMA+ESMROUS Ot*tLBRBEIVO/JONDRMEY FY —-SRICAIERUEY Bt / BAA. % 201125A 201 24655 (P48) {O's {USE TL 26,825 14.6 28,374 5.8 Berle 1,496 52.3 1,
Slide 34: ( Pharmarise
( Pharmarise ia HOLDINGS ACY BRIS DUT BME BAS BROKRICAIE PRN GAS BREDRODA. LEVMRI4OREIBHS (PF) ESS) aes ——8 este (%) 3000 — —50 2500 — _ 40 2000 — — 30 1500 — —20 1000 — 500 — ~ 10 2005 2006 2007 2008 2009% 2010 2011 2012 SARA SARA SARA SARA SARA SARA SAR SARA CPE) Pharmarise Holdings Corporation Co
Slide 35: Pharmarise
Pharmarise HOLDINGS ABISSITUC BY PICDUAECAUELE. R—-LN—VbEIECH PSL). http://www.pharmarise.com/